Business
SafeSpace Global Enters Letter of Intent with BMRT for Exclusive Deployment of Molecular-Level Weapons Detection Technology in U.S. Schools and Correctional Facilities
SafeSpace Global Enters Letter of Intent with BMRT for Exclusive Deployment of Molecular-Level Weapons Detection Technology in U.S. Schools and Correctional Facilities.
About this update from Safespace Global Corporation
[{"type":"text","content":"\r\n\r\n \r\n \r\n SafeSpace Global Enters Letter of Intent with BMRT for Exclusive Deployment of Molecular-Level Weapons Detection Technology in U.S. Schools and Correctional Facilities\r\n \r\n \r\n\r\n\r\nSafeSpace Global Enters Letter of Intent with BMRT for Exclusive Deployment of Molecular-Level Weapons Detection Technology in U.S. Schools and Correctional Facilities\r\n\r\n\r\n\r\n\r\n\r\nLetter of Intent Contemplates Joint Venture and Exclusive Deployment Rights Across Estimated $6 Billion Addressable Market Knoxville, TN, Dec. 18, 2025 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID:SSGC) (“SafeSpace Global” or the “Company”), a publicly traded artificial intelligence safety and security technology company, today announced the execution of a non-binding Letter of Intent (“LOI”) with Base Molecular Resonance™ Technologies (BMRT) to pursue the formation of a joint venture focused on the deployment of molecular-level weapons detection technology across K–12 schools and correctional facilities in the United States. Pursuant to the LOI, SafeSpace Global would receive exclusive rights, subject to execution of definitive agreements, to deploy BMRT’s proprietary molecular resonance detection technology within the U.S. K–12 education and correctional facility verticals. These sectors collectively represent an estimated addressable market exceeding $6 billion, based on publicly available industry data and internal estimates. BMRT Technology Overview Base Molecular Resonance™ Technologies (BMRT) is a deep-technology company specializing in molecular resonance-based detection systems designed to identify specific molecular signatures associated with weapons, narcotics, and other controlled materials at a distance. BMRT’s technology platform is supported by 20 patent assets and has undergone rigorous third-party validation testing in multiple blind and double blind studies. During such testing, BMRT reports successful detection of: • Concealed firearms and magazines at extended distances. • Weapon-related molecular signatures inside moving vehicles without line of sight. • Specific molecular signatures through certain barriers and obstructions, including water and concrete. BMRT has also been nominated for a 2026 Edison A...